• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
.Development of a method for determination of purity in tuberculosis therapeutic DNA vaccine based on ion exchange chromatography[J].Journal Of Pharmaceutical Research,2020,39(11):628-631[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2709times   Download 2375次 QR Code for this article
Scan with your phone!
基于离子交换色谱法检测结核治疗性DNA疫苗纯度的方法建立
孔雯雯1,周飞燕1,符美娟1,杨丽菲1,梁艳2,吴雪琼2,倪世明1,黄明1
Font:Larger+|Default|Smaller-
(1.广州白云山拜迪生物医药有限公司,广东 广州 511495;2.中国人民解放军总医院第八医学中心结核病重点实验室,北京 100091)
摘要:
目的 建立并验证结核治疗性DNA疫苗纯度的高效液相色谱测定方法。方法 采用TSK gel DNA-NPR(4.6 mm ×75 mm, 2.5 µm)色谱柱,流动相:以20 mmol·L-1 三羟甲基氨基甲烷(pH=9)为流动相A,以20 mmol·L-1三羟甲基氨基甲烷-1 mol·L-1 氯化钠(pH=9)为流动相B,梯度洗脱,柱温:25 ℃;流速:0.5 mL·min-1;检测波长:260 nm。结果 质粒DNA在0.5~2.5 µg的范围内与峰面积呈良好线性关系,R2=0.999 8,该法专属性、精密度和耐用性良好,检测限为0.001 mg·mL-1,供试品在 24 h内稳定。结论 该方法符合检测结核治疗性DNA疫苗纯度的要求,适用于该产品的质量控制。
关键词:  结核DNA疫苗  离子交换色谱法  高效液相色谱法  纯度
DOI:10.13506/j.cnki.jpr.2020.11.002
基金项目:国家科技重大专项资助(No.2018ZX10731301-005-003)
Publication Date:November 25, 2020
Development of a method for determination of purity in tuberculosis therapeutic DNA vaccine based on ion exchange chromatography
()
Abstract:
Objective To establish and validate a method of area normalization for detection of purity in the tuberculosis therapeutic DNA vaccine by high performance liquid chromatography (HPLC).Methods Chromatography was performed on TSK gel DNA-NPR (4.6 mm×75 mm, 2.5 µm),using 20 mmol·L-1 Tris buffer (pH=9) as mobile phase A, and 20 mmol·L-1 Tris-1 mol·L-1 sodium chloride solution (pH=9) as mobile phase B, with gradient elution at a flow rate of 0.5 mL·min-1. The detection wavelength was 260 nm at 25 ℃.Results The plasmid DNA content showed good linear relationship to peak area within a concentration range of 0.5~2.5 µg (R2=0.999 8). The method showed good specificity, precision and durability, of which the minimum detection limit was 0.001 mg·mL-1. Test solution was stable within 24 h. The purity in three batches of the tuberculosis therapeutic DNA vaccine were above 95%.Conclusion This method conforms to requirement of the purity testing of the tuberculosis therapeutic DNA vaccine content and purity,and be applied to quality control.
Key words:  Tuberculosis therapeutic DNA vaccine  Ion exchange chromatography  High performance liquid chromatography  Purity
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.